Mersana Therapeutics Inc (MRSN)
2.725
+0.14
(+5.62%)
USD |
NASDAQ |
May 17, 16:00
2.725
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Enterprise Value: 176.21M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 176.21M |
| May 16, 2024 | 157.85M |
| May 15, 2024 | 156.63M |
| May 14, 2024 | 161.52M |
| May 13, 2024 | 162.75M |
| May 10, 2024 | 173.76M |
| May 09, 2024 | 143.78M |
| May 08, 2024 | 258.19M |
| May 07, 2024 | 273.48M |
| May 06, 2024 | 270.42M |
| May 03, 2024 | 265.53M |
| May 02, 2024 | 253.29M |
| May 01, 2024 | 254.52M |
| April 30, 2024 | 230.04M |
| April 29, 2024 | 228.82M |
| April 26, 2024 | 201.90M |
| April 25, 2024 | 190.89M |
| April 24, 2024 | 194.56M |
| April 23, 2024 | 234.94M |
| April 22, 2024 | 227.60M |
| April 19, 2024 | 239.83M |
| April 18, 2024 | 250.85M |
| April 17, 2024 | 272.87M |
| April 16, 2024 | 302.24M |
| April 15, 2024 | 305.91M |
| Date | Value |
|---|---|
| April 12, 2024 | 308.35M |
| April 11, 2024 | 297.34M |
| April 10, 2024 | 295.50M |
| April 09, 2024 | 343.83M |
| April 08, 2024 | 351.17M |
| April 05, 2024 | 365.86M |
| April 04, 2024 | 362.19M |
| April 03, 2024 | 386.66M |
| April 02, 2024 | 358.52M |
| April 01, 2024 | 382.99M |
| March 31, 2024 | 390.33M |
| March 28, 2024 | 359.58M |
| March 27, 2024 | 360.80M |
| March 26, 2024 | 337.75M |
| March 25, 2024 | 334.11M |
| March 22, 2024 | 386.27M |
| March 21, 2024 | 399.61M |
| March 20, 2024 | 403.25M |
| March 19, 2024 | 417.81M |
| March 18, 2024 | 405.68M |
| March 15, 2024 | 427.51M |
| March 14, 2024 | 423.27M |
| March 13, 2024 | 512.43M |
| March 12, 2024 | 500.30M |
| March 11, 2024 | 506.36M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-133.82M
Minimum
Aug 02 2023
1.624B
Maximum
Dec 23 2020
432.93M
Average
316.76M
Median
Mar 06 2023
Enterprise Value Benchmarks
| Amicus Therapeutics Inc | 2.983B |
| Geron Corp | 1.900B |
| Insmed Inc | 4.248B |
| Altimmune Inc | 385.90M |
| InfuSystems Holdings Inc | 166.25M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.31M |
| Revenue (Quarterly) | 9.245M |
| Total Expenses (Quarterly) | 30.25M |
| EPS Diluted (Quarterly) | -0.16 |
| Profit Margin (Quarterly) | -208.8% |
| Earnings Yield | -41.76% |
| Normalized Earnings Yield | -39.11 |